Chinese police yesterday accused a British executive of drugmaker GlaxoSmithKline (GSK) of leading a sprawling scheme to bribe doctors and hospitals to use its products.
The announcement was the first time a foreign employee in China of British-based GSK was accused in the investigation announced in in July last year.
It highlighted the widespread use of payments to doctors and hospitals by sellers of drugs and medical equipment in a state-run and poorly funded health system that Chinese leaders have promised to improve.
The executive, Mark Reilly, is accused of operating a “massive bribery network,” police official Gao Feng (高峰) said at a news conference.
He said the case had been handed over to prosecutors.
Beginning in January 2009, Reilly was accused of ordering his sales team to pay doctors, hospital officials and health institutions to use GSK’s products, said Gao, deputy director of the Chinese Ministry of Public Security’s economic crimes unit.
He said that resulted in “illegal revenue” of hundreds of millions of dollars.
Gao said that as far as he knew, Reilly still was in China, but he had no details of his status.
He said dozens of other people also were implicated, but he gave no names or other details.
Reilly is GSK’s senior vice president of pharmaceuticals for China and Hong Kong and former general manager for China.
Police previously identified four Chinese employees of GSK who they said confessed to bribery.
A second foreign drugmaker, AstraZeneca, said in July last year that police in Shanghai were investigating one of its salespeople.
The company has given no information since then.
Chinese state media have publicized the investigations of GSK and AstraZeneca.
However, economists who study Chinese healthcare say such payments are more widely used by China’s domestic drug manufacturers.
Doctors and hospitals routinely accept informal payments from patients and suppliers of medical goods to top up low salaries and cover gaps in budgets.
Hospitals also raise money by adding surcharges to drug prices and assigning employees sales quotas. That can also distort treatment by encouraging overuse of expensive drugs or procedures.
As a result of bribery, GSK was able to receive prices for its medications that were up to seven times the level of the same products sold in other countries, Gao said.
In a separate statement, police in the central city of Changsha, where the investigation began, said Reilly and two Chinese executives also are accused of bribing government officials in Beijing and Shanghai.
Police in Changsha said last July last year that employees appeared to be trying to evade GSK’s internal anti-bribery controls by making payments totaling as much as 3 billion yuan (US$490 million) to a travel agency that gave back at least part of that money.
One of the detained Chinese employees was shown on state television at that time describing how he paid bribes to government officials to win support for use of the company’s medications.
The British embassy in Beijing said it could not comment while the case was underway and referred questions to GSK.
Gao said possible charges include bribing nongovernment workers and bribing corporate units, while GSK might face charges of corporate bribery.
The company has given the investigation its “full support and assistance,” Gao said.
The investigations coincide with efforts by Chinese Communist Party leaders to improve the nation’s health system and rein in surging costs of medicine and medical care that are fueling public frustration.
Under the current system, the state-set price to see an oncologist or other specialist is as little as 7 yuan, less than the cost of a hamburger and too little to cover a hospital’s expenses.
The top salary for an experienced physician might be as little as 6,000 yuan per month.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”